Stock 9267 GENKY DRUGSTORES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Genky DrugStores Co., Ltd.

Equities

9267

JP3282750003

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
5,630 JPY 0.00% Intraday chart for Genky DrugStores Co., Ltd. -2.76% +3.11%
Mar. 29 Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended March 2024 CI
Jan. 29 Genky DrugStores Co., Ltd. Provides Dividend Guidance for Year Ending June 20, 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The stock, which is currently worth 2024 to 0.61 times its sales, is clearly overvalued in comparison with peers.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Sales forecast by analysts have been recently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company sustains low margins.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
GENKY DRUGSTORES CO., LTD. Stock Genky DrugStores Co., Ltd.
+3.11% 559M -
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-31.79% 15.36B
B-
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-21.99% 12.45B
B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-22.64% 6.75B
B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.74% 6.14B
C
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-10.91% 6.07B
C+
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+0.58% 4.78B
D-
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+59.24% 4.53B -
C
CLICKS GROUP LIMITED Stock Clicks Group Limited
-9.00% 3.81B
B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-12.53% 3.43B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 9267 Stock
  4. Ratings Genky DrugStores Co., Ltd.